Medulloblastomas (MB), the most common malignant pediatric brain tumors, mainly show somatic heterozygous missense mutations of SMARCA4, which are suggested to have a dominant-negative effect resulting in a loss of function [15, 29, 44, 55]. Here, SMARCA4 is linked to medulloblastoma.